Oncology - Funding innovative technologies to revolutionize cancer research
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
View as a Web Page
Facebook Twitter Vimeo
News Medical
Oncology Newsletter
The latest oncology news from News Medical

TREM Proteins: Emerging Targets of Immunotherapy

TREM (triggering receptor expressed on myeloid cells) proteins are now promising targets in neurodegenerative diseases, inflammatory diseases, and cancers. Sino Biological has developed a panel of recombinant TREM protein and antibody reagents to support the study of the biology of this protein family.

Browse the full range now

Funding innovative technologies to revolutionize cancer research

In this interview, News-Medical interviews Michael Weingarten about his work as a director of the Small Business Innovation Research Development Center, helping to fund highly-innovative technologies that are revolutionizing cancer research.

Learn more here

Insight into the Breast Cancer Landscape with Breast Cancer Now

In this interview, we speak with Dr. Simon Vincent, Director of Research, Support, and Influencing at Breast Cancer Now, about the current landscape of breast cancer.

Discover more

AI-based system improves bladder cancer treatment response assessment

Read More

Extra copies of DNA explain insensitivity to chemotherapy in germ cell cancer

Read More

Study reveals key characteristics of immune cells in ovarian cancer

Read More

Study underscores the crucial role of genomic profiling in diagnosing and grading brain tumors

Read More

Adding immunotherapy to chemotherapy before surgery improves outcomes for NSCLC patients

Read More
AZoNetwork UK Ltd.
NEO, 9 Charlotte St, Manchester, M1 4ET, UK
44 (0)161 457 7150

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not Interested Anymore?
Unsubscribe or Update your Notification Preferences

Copyright © 2000-2022